Carl Zeiss Meditec AG (ETR:AFX)
Germany flag Germany · Delayed Price · Currency is EUR
27.76
+0.82 (3.04%)
Jun 24, 2026, 5:35 PM CET

Carl Zeiss Meditec AG Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Carl Zeiss Meditec AG stock has a consensus rating of "Hold" and an average price target of €30.05. The average 1-year stock price forecast is 8.25% higher than the current stock price, while the lowest is €21.70 (-21.83%) and the highest is €50.00 (+80.12%).

Price Target: €30.05 (+8.25%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price€21.70€30.05€29.00€50.00
Change-21.83%+8.25%+4.47%+80.12%
* Price targets were last updated on May 14, 2026.

Analyst Ratings

The average analyst rating for Carl Zeiss Meditec AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy111111
Buy211100
Hold121313131414
Sell111111
Strong Sell000000
Total161616161616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Hold
Maintains
€31.00€28.00
HoldMaintains€31.00€28.00+0.86%May 14, 2026
Kepler Capital
Kepler Capital
Hold
Maintains
€28.00
HoldMaintains€28.00+0.86%May 14, 2026
Deutsche Bank
Deutsche Bank
Hold
Maintains
€30.00
HoldMaintains€30.00+8.07%May 13, 2026
J.P. Morgan
J.P. Morgan
Sell
Maintains
€22.40€21.70
SellMaintains€22.40€21.70-21.83%May 13, 2026
UBS
UBS
Hold
Maintains
€25.00
HoldMaintains€25.00-9.94%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.19B
from 2.23B
Decreased by -1.68%
Revenue Next Year
2.31B
from 2.19B
Increased by 5.41%
EPS This Year
1.39
EPS Next Year
1.86
from 1.39
Increased by 34.01%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingSep 30, 2021Sep 30, 2022Sep 30, 2023Sep 30, 2024Sep 30, 2025Sep 30, 2026
Revenue
1.65B1.90B2.09B2.07B2.23B2.19B
Revenue Growth
23.31%15.55%9.80%-1.11%7.82%-1.68%
Gross Profit
967.21M1.13B1.21B1.09B1.18B1.13B
Gross Margin
58.73%59.26%57.71%52.69%52.76%51.40%
Operating Income
370.38M397.68M349.06M177.21M223.30M161.17M
Net Income
236.28M293.91M290.40M178.73M141.21M96.52M
EPS
-----1.39
Forward PE
57.1434.3025.6627.9920.7720.01
Dividend / Share
0.901.101.100.600.550.52
Dividend Growth
-22.22%--45.45%-8.33%-5.47%
Free Cash Flow
59.29M132.07M73.93M783.80M87.32M77.89M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High2.2B
Avg2.2B
Low2.2B

Revenue Growth

Revenue Growth202620272028
High
0.2%
Avg
-1.7%
Low
-2.8%

EPS Forecast

EPS202620272028
High1.59
Avg1.39
Low1.10

EPS Growth

EPS Growth202620272028
High
-31.3%
Avg
-40.1%
Low
-52.6%